Decreasing the Toxicity of Radiation Therapy: Radioprotectors and Radiomitigators Being Developed by the National Cancer Institute Through Small Business Innovation Research Contracts

With the intention of accelerating the translation of radiation-effect modulators, the Radiation Research Program at the National Cancer Institute collaborated with the SBIR Development Center to accelerate clinical translation of radiation-effect modulators. A summary of advances made through this collaboration has been previously described (Prasanna et al. Rad. Res. 2015). Here, we give an update on the SBIR funding for the development of radiation-effect modulators, which has resulted in multiple early phase clinical trials.

http://bit.ly/2Lx9Qqv